Evogene (EVGN) Q3 2024 Earnings
EVGN·Reported November 21, 2024·Before market open
Evogene reported Q3 2024 revenue of $1.7M, missed analyst consensus of $3.6M by $1.9M. Diluted EPS came in at $-1.31, missed the $-1.01 consensus by $0.30.
Revenue
$1.7Mmissed by $1.9M
Consensus: $3.6MDiluted EPS
$-1.31missed by $0.30
Consensus: $-1.01
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about Evogene's Q3 2024 earnings report.
Evogene (EVGN) reported Q3 2024 earnings on November 21, 2024 before market open.
Evogene reported revenue of $1.7M and diluted EPS of $-1.31 for Q3 2024.
Revenue missed the consensus estimate of $3.6M by $1.9M. EPS missed the consensus estimate of $-1.01 by $0.30.